Wang D - Search Results

1

Current Advance of Therapeutic Agents in Clinical Trials Potentially Targeting Tumor Plasticity.

Yang XG, Zhu LC, Wang YJ, Li YY, Wang D. Yang XG, et al. Among authors: wang yj, wang d. Front Oncol. 2019 Sep 10;9:887. doi: 10.3389/fonc.2019.00887. eCollection 2019. Front Oncol. 2019. PMID: 31552191 Free PMC article. Review.

2

Mitochondria-targeted prostate cancer therapy using a near-infrared fluorescence dye-monoamine oxidase A inhibitor conjugate.

Lv Q, Yang X, Wang M, Yang J, Qin Z, Kan Q, Zhang H, Wang Y, Wang D, He Z. Lv Q, et al. Among authors: wang y, wang m, wang d. J Control Release. 2018 Jun 10;279:234-242. doi: 10.1016/j.jconrel.2018.04.038. Epub 2018 Apr 19. J Control Release. 2018. PMID: 29679664

3

Repurposing antitubercular agent isoniazid for treatment of prostate cancer.

Lv Q , Wang D , Yang Z , Yang J , Zhang R , Yang X , Wang M , Wang Y . Lv Q , et al. Among authors: wang y, wang m, wang d. Biomater Sci. 2018 Dec 18;7(1):296-306. doi: 10.1039/c8bm01189c. Biomater Sci. 2018. PMID: 30468220

4

Design, Synthesis, and Evaluation of Monoamine Oxidase A Inhibitors⁻Indocyanine Dyes Conjugates as Targeted Antitumor Agents.

Yang XG, Mou YH, Wang YJ, Wang J, Li YY, Kong RH, Ding M, Wang D, Guo C. Yang XG, et al. Among authors: wang j, wang yj, wang d. Molecules. 2019 Apr 10;24(7):1400. doi: 10.3390/molecules24071400. Molecules. 2019. PMID: 30974737 Free PMC article.

5

Application of novel pH sensitive isoniazid-heptamethine carbocyanine dye conjugates against prostate cancer cells.

Yang XG, Li YF, Wang YJ, Kong RH, Wang D. Yang XG, et al. Among authors: wang yj, wang d. Pharmazie. 2020 Sep 1;75(9):412-416. doi: 10.1691/ph.2020.0521. Pharmazie. 2020. PMID: 32797765

6

Potential monoamine oxidase A inhibitor suppressing paclitaxel-resistant non-small cell lung cancer metastasis and growth.

Yang X, Zhao D, Li Y, Li Y, Cui W, Li Y, Li H, Li X, Wang D. Yang X, et al. Among authors: wang d. Thorac Cancer. 2020 Oct;11(10):2858-2866. doi: 10.1111/1759-7714.13617. Epub 2020 Sep 2. Thorac Cancer. 2020. PMID: 32875729 Free PMC article.

7

Design, synthesis and biological evaluation of novel heptamethine cyanine dye-erlotinib conjugates as antitumor agents.

Yang X, Hou Z, Wang D, Mou Y, Guo C. Yang X, et al. Among authors: wang d. Bioorg Med Chem Lett. 2020 Dec 1;30(23):127557. doi: 10.1016/j.bmcl.2020.127557. Epub 2020 Sep 16. Bioorg Med Chem Lett. 2020. PMID: 32949719

8

Repurposing of a monoamine oxidase A inhibitor‑heptamethine carbocyanine dye conjugate for paclitaxel‑resistant non‑small cell lung cancer.

Yang XG, Li YY, Zhao DX, Cui W, Li H, Li XY, Li YX, Wang D. Yang XG, et al. Among authors: wang d. Oncol Rep. 2021 Mar;45(3):1306-1314. doi: 10.3892/or.2021.7950. Epub 2021 Jan 22. Oncol Rep. 2021. PMID: 33650669

9

Doxorubicin-isoniazid conjugate regulates immune response and tumor microenvironment to enhance cancer therapy.

Jin C, Li J, Yang X, Zhou S, Li C, Yu J, Wang Z, Wang D, He Z, Jiang Y, Wang Y. Jin C, et al. Among authors: wang z, wang y, wang d. Int J Pharm. 2023 Jan 25;631:122509. doi: 10.1016/j.ijpharm.2022.122509. Epub 2022 Dec 19. Int J Pharm. 2023. PMID: 36549403

10

Bcl-X_L: A multifunctional anti-apoptotic protein.

Li M, Wang D, He J, Chen L, Li H. Li M, et al. Among authors: wang d. Pharmacol Res. 2020 Jan;151:104547. doi: 10.1016/j.phrs.2019.104547. Epub 2019 Nov 14. Pharmacol Res. 2020. PMID: 31734345 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63,456 results

Search Page

Filters